<DOC>
	<DOCNO>NCT00515320</DOCNO>
	<brief_summary>The purpose study assess effect fluoxetine orally dissolve tablet ( ODT ) repetitive behavior core domain child adolescents Autistic Disorder . The study also investigate effect fluoxetine improvement symptom effect daily live patient 's family .</brief_summary>
	<brief_title>Study Fluoxetine Autism</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Meets DSMIV criterion autistic disorder , . CYBOCSPDD score least 10 screen . Diagnosis Asperger Syndrome Pervasive Developmental Disorder Not Otherwise Specified , Rett Syndrome , Childhood Disintegrative Disorder . Patients plan commence cognitive behaviour therapy period study begin cognitive behaviour therapy within 8 week prior enrolment . Patients currently take fluoxetine previously take eligible study . Other protocoldefined Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Autism</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>Autistic Disorder</keyword>
	<keyword>Repetitive behavior</keyword>
	<keyword>SSRI</keyword>
	<keyword>Selective Serotonin Reuptake Inhibitor</keyword>
</DOC>